1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Viable Bone Matrix Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Viable Bone Matrix by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Viable Bone Matrix by Country/Region, 2017, 2022 & 2028 2.2 Viable Bone Matrix Segment by Type 2.2.1 Demineralized Bone Fibrous Matrix 2.2.2 Moldable Viable Bone Matrix 2.3 Viable Bone Matrix Sales by Type 2.3.1 Global Viable Bone Matrix Sales Market Share by Type (2017-2022) 2.3.2 Global Viable Bone Matrix Revenue and Market Share by Type (2017-2022) 2.3.3 Global Viable Bone Matrix Sale Price by Type (2017-2022) 2.4 Viable Bone Matrix Segment by Application 2.4.1 Hospital 2.4.2 Orthopedic Surgery Center 2.4.3 Others 2.5 Viable Bone Matrix Sales by Application 2.5.1 Global Viable Bone Matrix Sale Market Share by Application (2017-2022) 2.5.2 Global Viable Bone Matrix Revenue and Market Share by Application (2017-2022) 2.5.3 Global Viable Bone Matrix Sale Price by Application (2017-2022) 3 Global Viable Bone Matrix by Company 3.1 Global Viable Bone Matrix Breakdown Data by Company 3.1.1 Global Viable Bone Matrix Annual Sales by Company (2020-2022) 3.1.2 Global Viable Bone Matrix Sales Market Share by Company (2020-2022) 3.2 Global Viable Bone Matrix Annual Revenue by Company (2020-2022) 3.2.1 Global Viable Bone Matrix Revenue by Company (2020-2022) 3.2.2 Global Viable Bone Matrix Revenue Market Share by Company (2020-2022) 3.3 Global Viable Bone Matrix Sale Price by Company 3.4 Key Manufacturers Viable Bone Matrix Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Viable Bone Matrix Product Location Distribution 3.4.2 Players Viable Bone Matrix Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Viable Bone Matrix by Geographic Region 4.1 World Historic Viable Bone Matrix Market Size by Geographic Region (2017-2022) 4.1.1 Global Viable Bone Matrix Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Viable Bone Matrix Annual Revenue by Geographic Region 4.2 World Historic Viable Bone Matrix Market Size by Country/Region (2017-2022) 4.2.1 Global Viable Bone Matrix Annual Sales by Country/Region (2017-2022) 4.2.2 Global Viable Bone Matrix Annual Revenue by Country/Region 4.3 Americas Viable Bone Matrix Sales Growth 4.4 APAC Viable Bone Matrix Sales Growth 4.5 Europe Viable Bone Matrix Sales Growth 4.6 Middle East & Africa Viable Bone Matrix Sales Growth 5 Americas 5.1 Americas Viable Bone Matrix Sales by Country 5.1.1 Americas Viable Bone Matrix Sales by Country (2017-2022) 5.1.2 Americas Viable Bone Matrix Revenue by Country (2017-2022) 5.2 Americas Viable Bone Matrix Sales by Type 5.3 Americas Viable Bone Matrix Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Viable Bone Matrix Sales by Region 6.1.1 APAC Viable Bone Matrix Sales by Region (2017-2022) 6.1.2 APAC Viable Bone Matrix Revenue by Region (2017-2022) 6.2 APAC Viable Bone Matrix Sales by Type 6.3 APAC Viable Bone Matrix Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Viable Bone Matrix by Country 7.1.1 Europe Viable Bone Matrix Sales by Country (2017-2022) 7.1.2 Europe Viable Bone Matrix Revenue by Country (2017-2022) 7.2 Europe Viable Bone Matrix Sales by Type 7.3 Europe Viable Bone Matrix Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Viable Bone Matrix by Country 8.1.1 Middle East & Africa Viable Bone Matrix Sales by Country (2017-2022) 8.1.2 Middle East & Africa Viable Bone Matrix Revenue by Country (2017-2022) 8.2 Middle East & Africa Viable Bone Matrix Sales by Type 8.3 Middle East & Africa Viable Bone Matrix Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Viable Bone Matrix 10.3 Manufacturing Process Analysis of Viable Bone Matrix 10.4 Industry Chain Structure of Viable Bone Matrix 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Viable Bone Matrix Distributors 11.3 Viable Bone Matrix Customer 12 World Forecast Review for Viable Bone Matrix by Geographic Region 12.1 Global Viable Bone Matrix Market Size Forecast by Region 12.1.1 Global Viable Bone Matrix Forecast by Region (2023-2028) 12.1.2 Global Viable Bone Matrix Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Viable Bone Matrix Forecast by Type 12.7 Global Viable Bone Matrix Forecast by Application 13 Key Players Analysis 13.1 Surgalign Spine Technologies, Inc. 13.1.1 Surgalign Spine Technologies, Inc. Company Information 13.1.2 Surgalign Spine Technologies, Inc. Viable Bone Matrix Product Offered 13.1.3 Surgalign Spine Technologies, Inc. Viable Bone Matrix Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Surgalign Spine Technologies, Inc. Main Business Overview 13.1.5 Surgalign Spine Technologies, Inc. Latest Developments 13.2 Aziyo 13.2.1 Aziyo Company Information 13.2.2 Aziyo Viable Bone Matrix Product Offered 13.2.3 Aziyo Viable Bone Matrix Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Aziyo Main Business Overview 13.2.5 Aziyo Latest Developments 13.3 DJO 13.3.1 DJO Company Information 13.3.2 DJO Viable Bone Matrix Product Offered 13.3.3 DJO Viable Bone Matrix Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 DJO Main Business Overview 13.3.5 DJO Latest Developments 13.4 Spinal Elements, Inc. 13.4.1 Spinal Elements, Inc. Company Information 13.4.2 Spinal Elements, Inc. Viable Bone Matrix Product Offered 13.4.3 Spinal Elements, Inc. Viable Bone Matrix Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Spinal Elements, Inc. Main Business Overview 13.4.5 Spinal Elements, Inc. Latest Developments 13.5 Arthrex 13.5.1 Arthrex Company Information 13.5.2 Arthrex Viable Bone Matrix Product Offered 13.5.3 Arthrex Viable Bone Matrix Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 Arthrex Main Business Overview 13.5.5 Arthrex Latest Developments 13.6 DePuy Synthes 13.6.1 DePuy Synthes Company Information 13.6.2 DePuy Synthes Viable Bone Matrix Product Offered 13.6.3 DePuy Synthes Viable Bone Matrix Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 DePuy Synthes Main Business Overview 13.6.5 DePuy Synthes Latest Developments 13.7 SurGenTec 13.7.1 SurGenTec Company Information 13.7.2 SurGenTec Viable Bone Matrix Product Offered 13.7.3 SurGenTec Viable Bone Matrix Sales, Revenue, Price and Gross Margin (2020-2022) 13.7.4 SurGenTec Main Business Overview 13.7.5 SurGenTec Latest Developments 13.8 Medline Industries, LP 13.8.1 Medline Industries, LP Company Information 13.8.2 Medline Industries, LP Viable Bone Matrix Product Offered 13.8.3 Medline Industries, LP Viable Bone Matrix Sales, Revenue, Price and Gross Margin (2020-2022) 13.8.4 Medline Industries, LP Main Business Overview 13.8.5 Medline Industries, LP Latest Developments 13.9 Stryker 13.9.1 Stryker Company Information 13.9.2 Stryker Viable Bone Matrix Product Offered 13.9.3 Stryker Viable Bone Matrix Sales, Revenue, Price and Gross Margin (2020-2022) 13.9.4 Stryker Main Business Overview 13.9.5 Stryker Latest Developments 13.10 Surgalign Spine Technologies, Inc. 13.10.1 Surgalign Spine Technologies, Inc. Company Information 13.10.2 Surgalign Spine Technologies, Inc. Viable Bone Matrix Product Offered 13.10.3 Surgalign Spine Technologies, Inc. Viable Bone Matrix Sales, Revenue, Price and Gross Margin (2020-2022) 13.10.4 Surgalign Spine Technologies, Inc. Main Business Overview 13.10.5 Surgalign Spine Technologies, Inc. Latest Developments 13.11 SurGenTec 13.11.1 SurGenTec Company Information 13.11.2 SurGenTec Viable Bone Matrix Product Offered 13.11.3 SurGenTec Viable Bone Matrix Sales, Revenue, Price and Gross Margin (2020-2022) 13.11.4 SurGenTec Main Business Overview 13.11.5 SurGenTec Latest Developments 13.12 XTANT MEDICAL 13.12.1 XTANT MEDICAL Company Information 13.12.2 XTANT MEDICAL Viable Bone Matrix Product Offered 13.12.3 XTANT MEDICAL Viable Bone Matrix Sales, Revenue, Price and Gross Margin (2020-2022) 13.12.4 XTANT MEDICAL Main Business Overview 13.12.5 XTANT MEDICAL Latest Developments 13.13 Zimmer Biomet 13.13.1 Zimmer Biomet Company Information 13.13.2 Zimmer Biomet Viable Bone Matrix Product Offered 13.13.3 Zimmer Biomet Viable Bone Matrix Sales, Revenue, Price and Gross Margin (2020-2022) 13.13.4 Zimmer Biomet Main Business Overview 13.13.5 Zimmer Biomet Latest Developments 13.14 VIVEX Biologics 13.14.1 VIVEX Biologics Company Information 13.14.2 VIVEX Biologics Viable Bone Matrix Product Offered 13.14.3 VIVEX Biologics Viable Bone Matrix Sales, Revenue, Price and Gross Margin (2020-2022) 13.14.4 VIVEX Biologics Main Business Overview 13.14.5 VIVEX Biologics Latest Developments 14 Research Findings and Conclusion

List of Tables Table 1. Viable Bone Matrix Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Viable Bone Matrix Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Demineralized Bone Fibrous Matrix Table 4. Major Players of Moldable Viable Bone Matrix Table 5. Global Viable Bone Matrix Sales by Type (2017-2022) & (Kg) Table 6. Global Viable Bone Matrix Sales Market Share by Type (2017-2022) Table 7. Global Viable Bone Matrix Revenue by Type (2017-2022) & ($ million) Table 8. Global Viable Bone Matrix Revenue Market Share by Type (2017-2022) Table 9. Global Viable Bone Matrix Sale Price by Type (2017-2022) & (US$/Gram) Table 10. Global Viable Bone Matrix Sales by Application (2017-2022) & (Kg) Table 11. Global Viable Bone Matrix Sales Market Share by Application (2017-2022) Table 12. Global Viable Bone Matrix Revenue by Application (2017-2022) Table 13. Global Viable Bone Matrix Revenue Market Share by Application (2017-2022) Table 14. Global Viable Bone Matrix Sale Price by Application (2017-2022) & (US$/Gram) Table 15. Global Viable Bone Matrix Sales by Company (2020-2022) & (Kg) Table 16. Global Viable Bone Matrix Sales Market Share by Company (2020-2022) Table 17. Global Viable Bone Matrix Revenue by Company (2020-2022) ($ Millions) Table 18. Global Viable Bone Matrix Revenue Market Share by Company (2020-2022) Table 19. Global Viable Bone Matrix Sale Price by Company (2020-2022) & (US$/Gram) Table 20. Key Manufacturers Viable Bone Matrix Producing Area Distribution and Sales Area Table 21. Players Viable Bone Matrix Products Offered Table 22. Viable Bone Matrix Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Viable Bone Matrix Sales by Geographic Region (2017-2022) & (Kg) Table 26. Global Viable Bone Matrix Sales Market Share Geographic Region (2017-2022) Table 27. Global Viable Bone Matrix Revenue by Geographic Region (2017-2022) & ($ millions) Table 28. Global Viable Bone Matrix Revenue Market Share by Geographic Region (2017-2022) Table 29. Global Viable Bone Matrix Sales by Country/Region (2017-2022) & (Kg) Table 30. Global Viable Bone Matrix Sales Market Share by Country/Region (2017-2022) Table 31. Global Viable Bone Matrix Revenue by Country/Region (2017-2022) & ($ millions) Table 32. Global Viable Bone Matrix Revenue Market Share by Country/Region (2017-2022) Table 33. Americas Viable Bone Matrix Sales by Country (2017-2022) & (Kg) Table 34. Americas Viable Bone Matrix Sales Market Share by Country (2017-2022) Table 35. Americas Viable Bone Matrix Revenue by Country (2017-2022) & ($ Millions) Table 36. Americas Viable Bone Matrix Revenue Market Share by Country (2017-2022) Table 37. Americas Viable Bone Matrix Sales by Type (2017-2022) & (Kg) Table 38. Americas Viable Bone Matrix Sales Market Share by Type (2017-2022) Table 39. Americas Viable Bone Matrix Sales by Application (2017-2022) & (Kg) Table 40. Americas Viable Bone Matrix Sales Market Share by Application (2017-2022) Table 41. APAC Viable Bone Matrix Sales by Region (2017-2022) & (Kg) Table 42. APAC Viable Bone Matrix Sales Market Share by Region (2017-2022) Table 43. APAC Viable Bone Matrix Revenue by Region (2017-2022) & ($ Millions) Table 44. APAC Viable Bone Matrix Revenue Market Share by Region (2017-2022) Table 45. APAC Viable Bone Matrix Sales by Type (2017-2022) & (Kg) Table 46. APAC Viable Bone Matrix Sales Market Share by Type (2017-2022) Table 47. APAC Viable Bone Matrix Sales by Application (2017-2022) & (Kg) Table 48. APAC Viable Bone Matrix Sales Market Share by Application (2017-2022) Table 49. Europe Viable Bone Matrix Sales by Country (2017-2022) & (Kg) Table 50. Europe Viable Bone Matrix Sales Market Share by Country (2017-2022) Table 51. Europe Viable Bone Matrix Revenue by Country (2017-2022) & ($ Millions) Table 52. Europe Viable Bone Matrix Revenue Market Share by Country (2017-2022) Table 53. Europe Viable Bone Matrix Sales by Type (2017-2022) & (Kg) Table 54. Europe Viable Bone Matrix Sales Market Share by Type (2017-2022) Table 55. Europe Viable Bone Matrix Sales by Application (2017-2022) & (Kg) Table 56. Europe Viable Bone Matrix Sales Market Share by Application (2017-2022) Table 57. Middle East & Africa Viable Bone Matrix Sales by Country (2017-2022) & (Kg) Table 58. Middle East & Africa Viable Bone Matrix Sales Market Share by Country (2017-2022) Table 59. Middle East & Africa Viable Bone Matrix Revenue by Country (2017-2022) & ($ Millions) Table 60. Middle East & Africa Viable Bone Matrix Revenue Market Share by Country (2017-2022) Table 61. Middle East & Africa Viable Bone Matrix Sales by Type (2017-2022) & (Kg) Table 62. Middle East & Africa Viable Bone Matrix Sales Market Share by Type (2017-2022) Table 63. Middle East & Africa Viable Bone Matrix Sales by Application (2017-2022) & (Kg) Table 64. Middle East & Africa Viable Bone Matrix Sales Market Share by Application (2017-2022) Table 65. Key Market Drivers & Growth Opportunities of Viable Bone Matrix Table 66. Key Market Challenges & Risks of Viable Bone Matrix Table 67. Key Industry Trends of Viable Bone Matrix Table 68. Viable Bone Matrix Raw Material Table 69. Key Suppliers of Raw Materials Table 70. Viable Bone Matrix Distributors List Table 71. Viable Bone Matrix Customer List Table 72. Global Viable Bone Matrix Sales Forecast by Region (2023-2028) & (Kg) Table 73. Global Viable Bone Matrix Sales Market Forecast by Region Table 74. Global Viable Bone Matrix Revenue Forecast by Region (2023-2028) & ($ millions) Table 75. Global Viable Bone Matrix Revenue Market Share Forecast by Region (2023-2028) Table 76. Americas Viable Bone Matrix Sales Forecast by Country (2023-2028) & (Kg) Table 77. Americas Viable Bone Matrix Revenue Forecast by Country (2023-2028) & ($ millions) Table 78. APAC Viable Bone Matrix Sales Forecast by Region (2023-2028) & (Kg) Table 79. APAC Viable Bone Matrix Revenue Forecast by Region (2023-2028) & ($ millions) Table 80. Europe Viable Bone Matrix Sales Forecast by Country (2023-2028) & (Kg) Table 81. Europe Viable Bone Matrix Revenue Forecast by Country (2023-2028) & ($ millions) Table 82. Middle East & Africa Viable Bone Matrix Sales Forecast by Country (2023-2028) & (Kg) Table 83. Middle East & Africa Viable Bone Matrix Revenue Forecast by Country (2023-2028) & ($ millions) Table 84. Global Viable Bone Matrix Sales Forecast by Type (2023-2028) & (Kg) Table 85. Global Viable Bone Matrix Sales Market Share Forecast by Type (2023-2028) Table 86. Global Viable Bone Matrix Revenue Forecast by Type (2023-2028) & ($ Millions) Table 87. Global Viable Bone Matrix Revenue Market Share Forecast by Type (2023-2028) Table 88. Global Viable Bone Matrix Sales Forecast by Application (2023-2028) & (Kg) Table 89. Global Viable Bone Matrix Sales Market Share Forecast by Application (2023-2028) Table 90. Global Viable Bone Matrix Revenue Forecast by Application (2023-2028) & ($ Millions) Table 91. Global Viable Bone Matrix Revenue Market Share Forecast by Application (2023-2028) Table 92. Surgalign Spine Technologies, Inc. Basic Information, Viable Bone Matrix Manufacturing Base, Sales Area and Its Competitors Table 93. Surgalign Spine Technologies, Inc. Viable Bone Matrix Product Offered Table 94. Surgalign Spine Technologies, Inc. Viable Bone Matrix Sales (Kg), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2020-2022) Table 95. Surgalign Spine Technologies, Inc. Main Business Table 96. Surgalign Spine Technologies, Inc. Latest Developments Table 97. Aziyo Basic Information, Viable Bone Matrix Manufacturing Base, Sales Area and Its Competitors Table 98. Aziyo Viable Bone Matrix Product Offered Table 99. Aziyo Viable Bone Matrix Sales (Kg), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2020-2022) Table 100. Aziyo Main Business Table 101. Aziyo Latest Developments Table 102. DJO Basic Information, Viable Bone Matrix Manufacturing Base, Sales Area and Its Competitors Table 103. DJO Viable Bone Matrix Product Offered Table 104. DJO Viable Bone Matrix Sales (Kg), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2020-2022) Table 105. DJO Main Business Table 106. DJO Latest Developments Table 107. Spinal Elements, Inc. Basic Information, Viable Bone Matrix Manufacturing Base, Sales Area and Its Competitors Table 108. Spinal Elements, Inc. Viable Bone Matrix Product Offered Table 109. Spinal Elements, Inc. Viable Bone Matrix Sales (Kg), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2020-2022) Table 110. Spinal Elements, Inc. Main Business Table 111. Spinal Elements, Inc. Latest Developments Table 112. Arthrex Basic Information, Viable Bone Matrix Manufacturing Base, Sales Area and Its Competitors Table 113. Arthrex Viable Bone Matrix Product Offered Table 114. Arthrex Viable Bone Matrix Sales (Kg), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2020-2022) Table 115. Arthrex Main Business Table 116. Arthrex Latest Developments Table 117. DePuy Synthes Basic Information, Viable Bone Matrix Manufacturing Base, Sales Area and Its Competitors Table 118. DePuy Synthes Viable Bone Matrix Product Offered Table 119. DePuy Synthes Viable Bone Matrix Sales (Kg), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2020-2022) Table 120. DePuy Synthes Main Business Table 121. DePuy Synthes Latest Developments Table 122. SurGenTec Basic Information, Viable Bone Matrix Manufacturing Base, Sales Area and Its Competitors Table 123. SurGenTec Viable Bone Matrix Product Offered Table 124. SurGenTec Viable Bone Matrix Sales (Kg), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2020-2022) Table 125. SurGenTec Main Business Table 126. SurGenTec Latest Developments Table 127. Medline Industries, LP Basic Information, Viable Bone Matrix Manufacturing Base, Sales Area and Its Competitors Table 128. Medline Industries, LP Viable Bone Matrix Product Offered Table 129. Medline Industries, LP Viable Bone Matrix Sales (Kg), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2020-2022) Table 130. Medline Industries, LP Main Business Table 131. Medline Industries, LP Latest Developments Table 132. Stryker Basic Information, Viable Bone Matrix Manufacturing Base, Sales Area and Its Competitors Table 133. Stryker Viable Bone Matrix Product Offered Table 134. Stryker Viable Bone Matrix Sales (Kg), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2020-2022) Table 135. Stryker Main Business Table 136. Stryker Latest Developments Table 137. Surgalign Spine Technologies, Inc. Basic Information, Viable Bone Matrix Manufacturing Base, Sales Area and Its Competitors Table 138. Surgalign Spine Technologies, Inc. Viable Bone Matrix Product Offered Table 139. Surgalign Spine Technologies, Inc. Viable Bone Matrix Sales (Kg), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2020-2022) Table 140. Surgalign Spine Technologies, Inc. Main Business Table 141. Surgalign Spine Technologies, Inc. Latest Developments Table 142. SurGenTec Basic Information, Viable Bone Matrix Manufacturing Base, Sales Area and Its Competitors Table 143. SurGenTec Viable Bone Matrix Product Offered Table 144. SurGenTec Viable Bone Matrix Sales (Kg), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2020-2022) Table 145. SurGenTec Main Business Table 146. SurGenTec Latest Developments Table 147. XTANT MEDICAL Basic Information, Viable Bone Matrix Manufacturing Base, Sales Area and Its Competitors Table 148. XTANT MEDICAL Viable Bone Matrix Product Offered Table 149. XTANT MEDICAL Viable Bone Matrix Sales (Kg), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2020-2022) Table 150. XTANT MEDICAL Main Business Table 151. XTANT MEDICAL Latest Developments Table 152. Zimmer Biomet Basic Information, Viable Bone Matrix Manufacturing Base, Sales Area and Its Competitors Table 153. Zimmer Biomet Viable Bone Matrix Product Offered Table 154. Zimmer Biomet Viable Bone Matrix Sales (Kg), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2020-2022) Table 155. Zimmer Biomet Main Business Table 156. Zimmer Biomet Latest Developments Table 157. VIVEX Biologics Basic Information, Viable Bone Matrix Manufacturing Base, Sales Area and Its Competitors Table 158. VIVEX Biologics Viable Bone Matrix Product Offered Table 159. VIVEX Biologics Viable Bone Matrix Sales (Kg), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2020-2022) Table 160. VIVEX Biologics Main Business Table 161. VIVEX Biologics Latest Developments List of Figures Figure 1. Picture of Viable Bone Matrix Figure 2. Viable Bone Matrix Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Viable Bone Matrix Sales Growth Rate 2017-2028 (Kg) Figure 7. Global Viable Bone Matrix Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Viable Bone Matrix Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Demineralized Bone Fibrous Matrix Figure 10. Product Picture of Moldable Viable Bone Matrix Figure 11. Global Viable Bone Matrix Sales Market Share by Type in 2021 Figure 12. Global Viable Bone Matrix Revenue Market Share by Type (2017-2022) Figure 13. Viable Bone Matrix Consumed in Hospital Figure 14. Global Viable Bone Matrix Market: Hospital (2017-2022) & (Kg) Figure 15. Viable Bone Matrix Consumed in Orthopedic Surgery Center Figure 16. Global Viable Bone Matrix Market: Orthopedic Surgery Center (2017-2022) & (Kg) Figure 17. Viable Bone Matrix Consumed in Others Figure 18. Global Viable Bone Matrix Market: Others (2017-2022) & (Kg) Figure 19. Global Viable Bone Matrix Sales Market Share by Application (2017-2022) Figure 20. Global Viable Bone Matrix Revenue Market Share by Application in 2021 Figure 21. Viable Bone Matrix Revenue Market by Company in 2021 ($ Million) Figure 22. Global Viable Bone Matrix Revenue Market Share by Company in 2021 Figure 23. Global Viable Bone Matrix Sales Market Share by Geographic Region (2017-2022) Figure 24. Global Viable Bone Matrix Revenue Market Share by Geographic Region in 2021 Figure 25. Global Viable Bone Matrix Sales Market Share by Region (2017-2022) Figure 26. Global Viable Bone Matrix Revenue Market Share by Country/Region in 2021 Figure 27. Americas Viable Bone Matrix Sales 2017-2022 (Kg) Figure 28. Americas Viable Bone Matrix Revenue 2017-2022 ($ Millions) Figure 29. APAC Viable Bone Matrix Sales 2017-2022 (Kg) Figure 30. APAC Viable Bone Matrix Revenue 2017-2022 ($ Millions) Figure 31. Europe Viable Bone Matrix Sales 2017-2022 (Kg) Figure 32. Europe Viable Bone Matrix Revenue 2017-2022 ($ Millions) Figure 33. Middle East & Africa Viable Bone Matrix Sales 2017-2022 (Kg) Figure 34. Middle East & Africa Viable Bone Matrix Revenue 2017-2022 ($ Millions) Figure 35. Americas Viable Bone Matrix Sales Market Share by Country in 2021 Figure 36. Americas Viable Bone Matrix Revenue Market Share by Country in 2021 Figure 37. United States Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 38. Canada Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 39. Mexico Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 40. Brazil Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 41. APAC Viable Bone Matrix Sales Market Share by Region in 2021 Figure 42. APAC Viable Bone Matrix Revenue Market Share by Regions in 2021 Figure 43. China Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 44. Japan Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 45. South Korea Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 46. Southeast Asia Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 47. India Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 48. Australia Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 49. Europe Viable Bone Matrix Sales Market Share by Country in 2021 Figure 50. Europe Viable Bone Matrix Revenue Market Share by Country in 2021 Figure 51. Germany Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 52. France Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 53. UK Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 54. Italy Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 55. Russia Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 56. Middle East & Africa Viable Bone Matrix Sales Market Share by Country in 2021 Figure 57. Middle East & Africa Viable Bone Matrix Revenue Market Share by Country in 2021 Figure 58. Egypt Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 59. South Africa Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 60. Israel Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 61. Turkey Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 62. GCC Country Viable Bone Matrix Revenue Growth 2017-2022 ($ Millions) Figure 63. Manufacturing Cost Structure Analysis of Viable Bone Matrix in 2021 Figure 64. Manufacturing Process Analysis of Viable Bone Matrix Figure 65. Industry Chain Structure of Viable Bone Matrix Figure 66. Channels of Distribution Figure 67. Distributors Profiles